October 29, 2013 | Hong Kong communication and industrial mogul Li Ka-shing is investing $6 million in Israeli startup MeMed, “Calcalist” reports. This is Li’s second investment in Israeli biomed and 20th in Israel overall. MeMed develops technology for disease diagnosis, which enables doctor to differentiate between different types of bacteria and between bacteria and viruses, thus helping them to decide which antibiotics to prescribe.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments